Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.0850 (15.57%) ($5.0850 - $5.0850) on Thu. Jun. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.54% (three month average) | RSI | 84 | Latest Price | $5.0850(15.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 9.1% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) XAR(12%) UNG(41%) XLB(12%) SDY(20%) VFMO(11%) | Factors Impacting CAPR price | CAPR will decline at least -2.27% in a week (0% probabilities). IWD(1%) LIT(16%) IBB(13%) IYT(15%) IWN(33%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.27% (StdDev 4.54%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $4.6(10.54%) | 10 Day Moving Average | $4.47(13.76%) | 20 Day Moving Average | $4.15(22.53%) | To recent high | -4.8% | To recent low | 1.1% | Market Cap | $100m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |